​

Funding Round

Series C - PhaseBio Pharmaceuticals

Series C - PhaseBio Pharmaceuticals

Investment Firm

Overview

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

Announced Date

Mar 12, 2015

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

AstraZeneca

AstraZeneca

No designation

Participant Investors

5

Investor Name
Participant InvestorJohnson & Johnson Development Corporation
Participant InvestorFletcher Spaght, Inc.
Participant InvestorHatteras Venture Partners
Participant InvestorAstraZeneca
Participant InvestorNew Enterprise Associates

Round Details and Background

PhaseBio Pharmaceuticals raised $40000000 on 2015-03-12 in Series C

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

Company Funding History

11

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 12, 2009
Debt Financing - PhaseBio Pharmaceuticals
-1.0M
Jun 05, 2012
Series B - PhaseBio Pharmaceuticals
5-23.0M
Oct 24, 2007
Venture Round - PhaseBio Pharmaceuticals
3-6.6M
Jan 07, 2010
Series B - PhaseBio Pharmaceuticals
5-25.0M

Recent Activity

There is no recent news or activity for this profile.